← Back to Patent Explorer
US5283191A Expired / Lapsed US ⏱️ 0.0 years remaining

Mareks' disease virus vaccine

Assignee: Akzo NV
•
Filing: 1992-07-10
•
Granted: 1994-02-01
•
Expires: 2012-07-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention is concerned with the MD18 and MD20 polypeptides of Marek's Disease virus which can be used to vaccinate poultry against MD. The invention also relates to nucleic acid sequences encoding the MD18 or MD20 polypeptides. Said sequences can be used for the preparation of a subunit or vector vaccine.

Inventors

  • 👤 Robin W. Morgan
  • 👤 Johannes A. J. Claessens
  • 👤 Martha J. Willemse
  • 👤 Paulus J. A. Sondermeijer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 08:40
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/005; A; A61; A61P; A61P31/00; A61P31/12; A61K; A61K39/00; C12; C12N; C12N2710/00; C12N2710/00011; C12N2710/16011; C12N2710/16311; C12N2710/16322

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 52 words
An isolated and purified nucleic acid molecule encoding a Marek's disease virus polypeptide selected from the group consisting of: a. MD18 having an amino acid sequence shown in SEQ ID NO:2, b. MD20 having an amino acid sequence shown in SEQ ID NO:4 and c. an antigenic fragment of MD18 on MD20.
Claim 2
Dependent Claim 52 words
An isolated and purified nucleic acid molecule encoding a Marek's disease virus polypeptide selected from the group consisting of: a. MD18 having an amino acid sequence shown in SEQ ID NO:2, b. MD20 having an amino acid sequence shown in SEQ ID NO:4 and c. an antigenic fragment of MD18 on MD20.
Claim 3
Dependent Claim 39 words
An isolated and purified nucleic acid molecule which comprises a DNA sequence selected from the group consisting of SEQ ID:1, SEQ ID NO:3, and a DNA sequence encoding an antigenic fragment of SEQ ID NO:1 or SEQ ID NO:3.
Claim 4
Dependent Claim 39 words
An isolated and purified nucleic acid molecule which comprises a DNA sequence selected from the group consisting of SEQ ID:1, SEQ ID NO:3, and a DNA sequence encoding an antigenic fragment of SEQ ID NO:1 or SEQ ID NO:3.
Claim 5
Dependent Claim 22 words
A recombinant nucleic acid molecule according to claim 1, wherein the nucleic acid molecule is operably linked to an expression control sequence.
Claim 6
Dependent Claim 21 words
A recombinant nucleic acid molecule according to claim 2, wherein the DNA sequence is operably linked to an expression control sequence.
Claim 7
Dependent Claim 13 words
A host cell transformed with a nucleic acid molecule according to claim 1.
Claim 8
Dependent Claim 13 words
A host cell transformed with a nucleic acid sequence according to claim 2.
Claim 9
Dependent Claim 11 words
A viral vector comprising the nucleic acid molecule of claim 3.
Claim 10
Dependent Claim 10 words
A host cell transfected with the vector of claim 7.
Claim 11
Dependent Claim 14 words
A host cell transformed with a recombinant nucleic acid molecule according to claim 3.
Claim 12
Dependent Claim 11 words
A viral vector comprising the nucleic acid molecule of claim 4.
Claim 13
Dependent Claim 10 words
A host cell transfected with the vector of claim 10.
Claim 14
Dependent Claim 11 words
A vector comprising a nucleic acid molecule according to claim 1.
Claim 15
Dependent Claim 11 words
The vector of claim 12, wherein said vector is a virus.
Claim 16
Dependent Claim 11 words
A host cell containing a viral vector according to claim 13.
Claim 17
Dependent Claim 11 words
A vector comprising a nucleic acid molecule according to claim 2.
Claim 18
Dependent Claim 11 words
The vector of claim 15, wherein said vector is a virus.
Claim 19
Dependent Claim 11 words
A host cell containing a viral vector according to claim 16.

References Cited (Backward Citations)

WO1990002803A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1997-01-31 1997-08-02 1998-02-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2001-01-31 2001-08-02 2002-02-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2005-01-31 2005-08-02 2006-02-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag